Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0,21%
1 091,51
-2,30
-0,21%
—1 093,811 096,521 100,221 091,51——
SIXC
Communications
SIXC
Communications
SIXC
+0,22%
610,11
+1,34
+0,22%
—608,77608,77612,97608,77——
SIXE
Energy
SIXE
Energy
SIXE
-1,34%
1 237,98
-16,83
-1,34%
—1 254,811 253,011 253,871 226,33——
SIXI
Industrials
SIXI
Industrials
SIXI
-0,93%
1 744,71
-16,40
-0,93%
—1 761,111 764,271 766,881 744,71——
SIXM
Financials
SIXM
Financials
SIXM
-0,37%
640,18
-2,40
-0,37%
—642,58644,87648,48640,18——
SIXR
Staples
SIXR
Staples
SIXR
-0,18%
849,58
-1,55
-0,18%
—851,13855,66858,75845,56——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,23%
217,48
-0,50
-0,23%
—217,98217,98218,65216,88——
SIXT
Technology
SIXT
Technology
SIXT
+1,52%
3 260,69
+48,86
+1,52%
—3 211,833 227,213 268,383 226,55——
SIXU
Utilities
SIXU
Utilities
SIXU
-0,69%
942,45
-6,53
-0,69%
—948,98948,58957,83941,97——
SIXV
Health care
SIXV
Health care
SIXV
-0,52%
1 466,80
-7,72
-0,52%
—1 474,521 479,031 481,041 466,80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,22%
2 397,50
+5,38
+0,22%
—2 392,122 396,952 421,222 382,32——
STAR:NSE
Strides Pharma Science Ltd
1 037,40 INR
-1,52%
(-16,05) 1D
30-апр., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for STAR...
Open
1 050,00 INR
High
1 051,45 INR
Low
1 026,15 INR
Mkt. cap
95,56 млд
Avg. vol.
267,68 миң
Volume
202,49 миң
Dividend
0,39%
Quarterly dividend
1,00 INR
Ex dividend date
2025-ж., 22-июл.
P/E ratio
18,70
52-wk high
1 110,00 INR
52-wk low
615,00 INR
EPS
55,49 INR
Shares outstanding
89,55 млн
No. of employees
3 миң
News stories
From sources across the web
Profile
Strides Pharma Science Limited is an Indian pharmaceutical company, headquartered at Bangalore. The company manufactures pharmaceutical products, over-the-counter drugs and nutraceuticals. Products include softgel capsules, hard-gel capsules, tablets and dry and wet injectables. The company has 15 manufacturing sites in six countries and marketing presence in 50 countries. The company partners with generic companies to supply retail and hospital generics in injectable products and softgels. The company's stock trades on the Bombay Stock Exchange and on the National Stock Exchange of India. Strides Arcolab changed name to Strides Shasun Ltd after an amalgamation of Shasun Pharmaceuticals with Strides Arcolab. In September 2014, the Board of Directors of both the companies had approved a scheme of amalgamation between the two companies. Arun Kumar is the founder and chairman, and has been on the board as managing director since its inception. Wikipedia
About Strides Pharma Science Ltd
CEO-
Employees3,3 миң
Founded1990
HeadquartersBengaluru, Карнатака, Индия
SectorPharmaceutical industry
Websitestrides.com
Last report
2026-ж., 30-янв.
Fiscal Period
Q3 2026
Normalized EPS / Estimate
-/ -INR
Revenue / Estimate
11,95 млд/ (12,54 млд est.)INR
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
2025-ж. мар.
2025-ж. июн.
2025-ж. сен.
2025-ж. дек.
Revenue
11,90 млд
11,20 млд
12,21 млд
11,95 млд
Cost of goods sold
6,47 млд
4,44 млд
5,15 млд
4,63 млд
Cost of revenue
6,47 млд
4,44 млд
5,15 млд
4,63 млд
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,93 млд
2,26 млд
2,27 млд
2,30 млд
Operating expense
3,75 млд
5,06 млд
5,24 млд
5,46 млд
Total operating expenses
10,23 млд
9,51 млд
10,39 млд
10,09 млд
Operating income
1,68 млд
1,69 млд
1,82 млд
1,85 млд
Other non operating income
-836,32 млн
-388,77 млн
271,40 млн
1,07 млд
EBT including unusual items
1,06 млд
1,22 млд
1,53 млд
2,45 млд
EBT excluding unusual items
1,30 млд
1,30 млд
1,62 млд
2,49 млд
Income tax expense
207,59 млн
164,50 млн
215,93 млн
373,53 млн
Effective tax rate
19,51%
13,48%
14,10%
15,22%
Other operating expenses
334,18 млн
2,32 млд
2,47 млд
2,66 млд
Net income
821,94 млн
996,08 млн
1,28 млд
2,02 млд
Net profit margin
6,90%
8,90%
10,45%
16,92%
Earnings per share
-
-
-
-
Interest and investment income
479,95 млн
-
-
-
Interest expense
-89,02 млн
-
-461,27 млн
-433,79 млн
Net interest expenses
390,93 млн
-
-461,27 млн
-433,79 млн
Depreciation and amortization charges
488,60 млн
488,86 млн
496,43 млн
506,23 млн
EBITDA
2,08 млд
2,09 млд
2,31 млд
2,25 млд
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer